Home / Companies / Glaxosmithkline Llc / Trends
Glaxosmithkline Llc H-1B trends
Quarterly LCA aggregate trend points for Glaxosmithkline Llc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 64 | 39 | 20 | $84,060 | $77,366 | 61 | 95.3% |
| 2017 Q2 | 56 | 30 | 17 | $78,909 | $70,746 | 54 | 96.4% |
| 2018 Q2 | 60 | 40 | 20 | $96,063 | $93,647 | 59 | 98.3% |
| 2019 Q2 | 82 | 49 | 22 | $92,757 | $90,238 | 80 | 97.6% |
| 2020 Q1 | 9 | 8 | 5 | $126,432 | $118,532 | 8 | 88.9% |
| 2020 Q2 | 50 | 40 | 18 | $93,454 | $84,545 | 48 | 96.0% |
| 2020 Q3 | 20 | 15 | 12 | $104,125 | $92,524 | 18 | 90.0% |
| 2020 Q4 | 13 | 11 | 6 | $110,868 | $88,774 | 12 | 92.3% |
| 2021 Q1 | 11 | 10 | 9 | $109,742 | $104,112 | 11 | 100.0% |
| 2021 Q2 | 25 | 22 | 17 | $114,253 | $105,100 | 24 | 96.0% |
| 2021 Q3 | 53 | 40 | 24 | $120,473 | $102,631 | 51 | 96.2% |
| 2021 Q4 | 19 | 12 | 9 | $134,080 | $105,576 | 17 | 89.5% |
| 2022 Q1 | 16 | 15 | 12 | $122,504 | $101,274 | 16 | 100.0% |
| 2022 Q2 | 22 | 17 | 13 | $119,878 | $104,563 | 20 | 90.9% |
| 2022 Q3 | 12 | 12 | 7 | $120,588 | $107,404 | 12 | 100.0% |
| 2022 Q4 | 7 | 7 | 5 | $112,545 | $80,407 | 7 | 100.0% |
| 2023 Q1 | 12 | 12 | 9 | $131,930 | $103,076 | 11 | 91.7% |
| 2023 Q2 | 23 | 23 | 14 | $125,388 | $102,419 | 22 | 95.7% |
| 2023 Q3 | 22 | 19 | 10 | $115,544 | $88,750 | 22 | 100.0% |
| 2023 Q4 | 16 | 15 | 12 | $131,019 | $114,845 | 16 | 100.0% |
| 2024 Q1 | 9 | 8 | 7 | $162,979 | $151,036 | 8 | 88.9% |
| 2024 Q2 | 8 | 7 | 7 | $161,481 | $150,519 | 8 | 100.0% |
| 2024 Q3 | 18 | 16 | 9 | $123,356 | $105,586 | 18 | 100.0% |
| 2024 Q4 | 23 | 21 | 10 | $143,739 | $120,097 | 22 | 95.7% |
| 2025 Q1 | 6 | 6 | 6 | $149,322 | $135,945 | 6 | 100.0% |
| 2025 Q2 | 10 | 9 | 7 | $145,575 | $130,283 | 10 | 100.0% |
| 2025 Q3 | 20 | 18 | 9 | $126,871 | $107,259 | 19 | 95.0% |
| 2025 Q4 | 14 | 14 | 10 | $136,724 | $112,628 | 14 | 100.0% |
| 2026 Q2 | 30 | 27 | 15 | $130,449 | $116,738 | 30 | 100.0% |
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=glaxosmithkline+llc&metric=lca_countJSON